Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis

Mariana Conceição, Michal Shteinberg, Pieter Goeminne, Josje Altenburg, James D. Chalmers (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    1 Citation (Scopus)
    32 Downloads (Pure)

    Abstract

    INTRODUCTION: Pseudomonas aeruginosa is the most commonly isolated pathogen in bronchiectasis and is associated with worse outcomes. Eradication treatment is recommended by guidelines, but the evidence base is limited. The expected success rate of eradication in clinical practice is not known.

    METHODS: We conducted a systematic review and meta-analysis according to Meta-Analysis of Observational Studies in Epidemiology guidelines. PubMed, Embase, the Cochrane Database of Systematic Reviews and Clinicaltrials.gov were searched for studies investigating P. aeruginosa eradication treatment using antibiotics (systemic or inhaled) in patients with bronchiectasis. The primary outcome was the percentage of patients negative for P. aeruginosa at 12 months after eradication treatment. Cystic fibrosis was excluded.

    RESULTS: Six observational studies including 289 patients were included in the meta-analysis. Our meta-analysis found a 12-month P. aeruginosa eradication rate of 40% (95% CI 34-45%; p<0.00001), with no significant heterogeneity (I2=0%). Combined systemic and inhaled antibiotic treatment was associated with a higher eradication rate (48%, 95% CI 41-55%) than systemic antibiotics alone (27%, 13-45%).

    CONCLUSION: Eradication treatment in bronchiectasis results in eradication of P. aeruginosa from sputum in ∼40% of cases at 12 months. Combined systemic and inhaled antibiotics achieve higher eradication rates than systemic antibiotics alone.

    Original languageEnglish
    Article number230178
    Number of pages9
    JournalEuropean Respiratory Review
    Volume33
    Issue number171
    DOIs
    Publication statusPublished - 31 Jan 2024

    Keywords

    • Adult
    • Humans
    • Pseudomonas Infections/diagnosis
    • Administration, Inhalation
    • Anti-Bacterial Agents/adverse effects
    • Bronchiectasis/diagnosis
    • Cystic Fibrosis/complications
    • Pseudomonas aeruginosa

    ASJC Scopus subject areas

    • Pulmonary and Respiratory Medicine

    Fingerprint

    Dive into the research topics of 'Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis'. Together they form a unique fingerprint.

    Cite this